StemGen (Oxford BioMedica/Oxford Institute of Molecular Medicine)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameStemGen (Oxford BioMedica/Oxford Institute of Molecular Medicine)
Drug Alias Namestem cell gene therapy (Oxford BioMedica/Oxford Institute of Molecular Medicine)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionHIV replication inhibitorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsGenetic Diseases, InbornNeoplasmsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Biomedica PLCUniversity Of Oxford
Active IndicationsN/A
Inactive IndicationsGenetic Diseases, InbornNeoplasmsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A